AHA letter to Senators Rick Scott, R-Fla., Marco Rubio, R-Fla., and Tom Cotton, R-Ark., in respond to their questions on efforts to protect U.S. taxpayer-funded research developed at our member organizations from foreign threats.
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
AHA, others urge Senate HELP Committee to advance MEDS Act (S.2723).
AHA comments to the U.S. House of Representatives Committee on Education and Labor on provisions of the Ban Surprise Billing Act that will be marked up this week.
The AHA is pleased to support the U.S. House of Representatives Committee on Ways and Means legislation, the Consumer Protections Against Surprise Medical Bills Act of 2020.
AHA comments on the Centers for Medicare & Medicaid Services’ proposed regulation related to Medicaid program financing and supplemental payments.
AHA comments to CMS on the transparency in coverage proposed rule. The AHA appreciates the Departments of the Treasury, Labor, and Health and Human Services’ (collectively, the departments) effort to increase the availability of useful information for patients, specifically, the proposal to improve patient access to estimates of their individual cost-sharing liability prior to care.
A model comment letter on Proposed Rule: CMS–2393–P, Medicaid Program: Medicaid Fiscal Accountability Regulation (Vol. 84, No. 222), November 18, 2019 and CMS-2393-N (Vol. 84, No. 249) December 30, 2019, and the infographic "Financial Impact Analysis: Proposed Medicaid Fiscal Accountability Rule (MFAR) Could Result in Deep Medicaid Cuts."
The Medicare Payment Advisory Commission (MedPAC, or the Commission) will vote this month on payment recommendations for 2021.
The AHA commented on the Food and Drug Administration’s draft guidance for industry and FDA staff on clinical decision support software as part of the agency’s efforts to implement Section 3060(a) of the 21st Century Cures Act.
AHA urges CMS to reconsider its recent guidance to providers requiring them to document Medicare-Medicaid “crossover” bad debt in a manner that is neither standard practice for most hospitals nor consistent with current accounting standards.